|
31 March, 2025
|
ICON plc Schedules First Quarter 2025 Earnings Conference Call
|
|
|
05 March, 2025
|
ICON plc to Present at Upcoming Investor Conferences
|
|
|
19 February, 2025
|
ICON Reports Fourth Quarter and Full Year 2024 Results
|
|
|
30 January, 2025
|
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
|
|
|
29 January, 2025
|
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
|
|
|
14 January, 2025
|
ICON Issues Financial Guidance for Full Year 2025
|
|
|
08 January, 2025
|
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
|
|
|
07 January, 2025
|
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
|
23 December, 2024
|
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
|
|
|
18 December, 2024
|
ICON Announces Appointment of Chief Operating Officer
|
|
|
05 December, 2024
|
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
|
|
|
13 November, 2024
|
ICON plc to Present at the Jefferies London Healthcare Conference
|
|
|
23 October, 2024
|
ICON Reports Third Quarter 2024 Results
|
|
|
27 September, 2024
|
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
|
|
|
12 September, 2024
|
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
|
|
|
03 September, 2024
|
ICON plc to Present at the Baird 2024 Global Healthcare Conference
|
|
|
14 August, 2024
|
ICON Announces Appointment of New Chief Financial Officer
|
|
|
24 July, 2024
|
ICON Reports Second Quarter 2024 Results
|
|
|
24 July, 2024
|
ICON announces results of Annual General Meeting and changes to the Board of Directors
|
|
|
10 July, 2024
|
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
|
|
